At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ
我們正在追蹤 Merck 的市場擴張
全新 市場推廣與公關 活動 — 剛出現 6 個新訊號。
Merck 的國際擴張與競爭對手的比較
Merck你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Merck你 | 0 | 0 | — | 0 | 0 |
Senior Specialist, Image Data Analytics
查看招聘Rahway, NJ · 3日前
Senior Specialist, Image Data Analytics
查看招聘Cambridge, MA · 3日前
Senior Specialist, Image Data Analytics
查看招聘West Point, PA · 3日前
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
科倫博泰將在2026年ASCO會議上展示三種腫瘤產品的臨床數據,包括TROP2 ADC佳泰萊、RET抑制劑寧泰萊和新型ADC SKB500,用於多種癌症治療。
谷歌在Cloud Next 2026發布第八代TPU芯片,包括訓練用TPU 8T(速度提升3倍)和推理用TPU 8I(性能提升8倍),加劇與微軟和亞馬遜的雲端AI競爭。
D3 Bio的elisrasib單藥治療達到78%總緩解率,與pembrolizumab聯合達到81.3%總緩解率,用於一線KRAS G12C突變非小細胞肺癌,安全性良好。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Merck 業務、市場及增長訊號的快速解答。
